Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 806 results for "Treatment For Multiple Sclerosis"

Biogen and AbbVie Receive FDA Approval of Once-Monthly ZINBRYTA (Daclizumab) for Multiple Sclerosis

Biogen & AbbVie partnership wins US FDA approval for ZINBRYTA ...

Biotechnology company Biogen (NasdaqGS:BIIB) and AbbVie (NYSE:ABBV) on Friday jointly announced the receipt of US Food and Drug Administration (FDA) approval for ZINBRYTA (daclizumab), a new once-monthly, self-administered, subcutaneous treatment ... Bloomberg, 18 hours ago

31 images for Treatment For Multiple Sclerosis

ImperialValleyNews, 1 week ago
ImperialValleyNews, 1 week ago
Nasdaq, 14 hours ago
Health Service Journal, 1 day ago
Pharmaceutical Journal, 2 weeks ago
Pharmaceutical Journal, 2 weeks ago
Barchart, 1 week ago
Yahoo! Singapore, 1 week ago, 1 day ago
One News Page United Kingdom, 1 month ago

Biogen & AbbVie's Multiple Sclerosis Drug Gets FDA Nod

Biogen Inc. BIIB and AbbVie Inc. ABBV have gained FDA approval for their multiple sclerosis (MS) treatment, Zinbryta. The once-monthly, self-administered, subcutaneous treatment has been approved for relapsing forms of multiple sclerosis (RMS) in ...
 Nasdaq14 hours ago FDA approves new Biogen multiple sclerosis drug  Boston Globe3 days ago FDA approves AbbVie/Biogen's monthly MS jab, but with safety warnings  FierceBiotech2 days ago BIOGEN : AbbVie's Once-Monthly MS Injection Approved in U.S.  4 Traders3 days ago

Zinbryta approved to treat multiple sclerosis

The FDA has just approved Zinbryta (daclizumab) for the treatment of adults with relapsing forms of multiple sclerosis , an autoimmune disease of the central nervous system that disrupts communication between the brain and other parts of the body.
 Examiner.com1 day ago FDA Approves Monthly Zinbryta Injection For Patients With Multiple Sclerosis  Tech Times1 day ago Patients can lead near normal lives with available therapies  Sunday Observer2 days ago FDA Approves Zinbryta (daclizumab) to Treat Multiple Sclerosis  Drugs.com2 days ago

Fasting-Mimicking Diet Reduces Symptoms of Multiple Sclerosis

Multiple sclerosis is a neurological disease that affects an estimated 350,000 Americans, suggested the National Institute of Neurological Disorders and Stroke. Symptoms range from blurred vision to paralysis. Evidence is mounting that a diet ...
 MedIndia2 days ago Diet That Mimics Fasting Shown To Reduce Symptoms Of Multiple Sclerosis  Tech Times2 days ago Diet That Mimics Fasting May Also Reduce Multiple Sclerosis Symptoms  Lab Manager12 hours ago Fasting-mimicking diet may help decrease multiple sclerosis symptoms  News-Medical.Net3 days ago

Mitoxantrone for MS linked to colorectal cancer risk

medwireNews : Treatment with mitoxantrone for multiple sclerosis (MS) carries only a mildly increased risk of malignancy overall, but the risk of colorectal cancer and leukaemia is heightened, researchers have found. They report a threefold ...
 MedWire News1 week ago Multiple Sclerosis Drug Mitoxantrone Increases Colon Cancer Risk  Med India2 weeks ago

PhD defence: Product related factors influencing the immunogenicity of interferon beta-1b

from 10:30 to 11:30 Therapeutic interferon beta is the first line treatment of relapsing remitting Multiple Sclerosis. However, despite their success in improving patient wellbeing, all IFN╬▓ products encounter a significant problem: ...
 Universiteit Utrecht5 hours ago

Sanofi Genzyme Launches its vs.MS Global Campaign to Address the Physical and Emotional Burden of Multiple Sclerosis

Sanofi Genzyme, the specialty care global business unit of Sanofi, announced today the launch of vs.MS, a global initiative focused on highlighting and addressing the sometimes debilitating symptoms that accompany MS, as well as their daily impact ...
 Benzinga.com5 days ago Sanofi Genzyme forms multiple sclerosis research alliance with Johns Hopkins School of Medicine  Manufacturing Chemist1 week ago Sanofi, Johns Hopkins partner on multiple sclerosis research  Center Watch2 weeks ago Sanofi Genzyme Announces Multiple Sclerosis Research Collaboration with the Johns Hopkins School of Medicine  Nasdaq2 weeks ago
Tehran Times

Disturbing figures of MS in Iran

TEHRAN Iran stands first in the rise of Multiple Sclerosis among other states in the Middle East, the vice president of Iranian MS Society reported on Monday. Multiple Sclerosis (MS) is a complex neurological disorder most likely caused by ...
 Tehran Times5 days ago

Innate Immunotherapeutics, Gordon Capital Research - Initiation of Coverage May 2016

Taking the Pain out of Multiple Sclerosis Innate Immunotherapeutics Limited (ASX:IIL) is a clinical stage medical biotechnology company that has designed and developed a proprietary drug MIS416 - that targets the human innate immune system ...
 Finance News Network6 days ago

Grand View Research, Inc.: Multiple sclerosis therapeutics market size is expected to reach USD 24.8 billion by 2024: Grand View Research

The global multiple sclerosis therapeutics market is expected to reach USD 24.8 billion by 2024 according to a new report by Grand View Research, Inc. The presence of high unmet clinical needs in developing regions is one of the highest impact ...
 Bloomberg1 week ago Multiple Sclerosis Therapeutics Market Size Projected To Reach $24.8 Billion By 2024: Grand View Research, Inc.  International Business Times2 weeks ago Market Research Rerports Inc: World Intravenous Immunoglobulin (IVIG) Market is Expected to Reach $11.6 Billion, by 2021  Bloomberg20 hours ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - Treatment For Multiple Sclerosis
Get updated on latest news & your favorite topics right in your inbox!
More     Less